Product Information

EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB is a generic product labeled by Laurus Labs Limited, priced at $1.0725 per EA under NDC 42385091530. Its NADAC has been published 245 times since Mar 16, 2022.

FDA first approved this application on Dec 22, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB

Efavirenz, emtricitabine and tenofovir disoproxil fumarate
$1.0725per EA

Strength

600; 200; 300 mg/1; mg/1; mg/1

NDC

42385091530

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA213541

FDA Approved

12/22/2021

TE Code

AB

On Market Since

12/22/2021

Pharmacological Classes

Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inhibitors
Cytochrome P450 2C9 Inhibitors
Cytochrome P450 3A Inducers
Cytochrome P450 3A4 Inhibitors
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Non-Nucleoside Analog
Non-Nucleoside Reverse Transcriptase Inhibitors
Nucleoside Reverse Transcriptase Inhibitors
Nucleoside Reverse Transcriptase Inhibitors
Nucleosides
Nucleosides

Price Statistics

The NADAC for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB has been published 245 times since Mar 16, 2022, and over the history we have for it it has declined 77.6%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0725 per EA
All-time high$5.4841 (Dec 14, 2022)
All-time low$1.0725 (Nov 18, 2026)
52-week high$1.4315
52-week low$1.0725
Median price$1.4793
Average price$2.5378
Largest weekly change-74.7% (Aug 23, 2023)
Weeks tracked245
Tracking sinceMar 16, 2022

Price History

1W

-3.2%

1M

-4.7%

3M

-7.9%

6M

-9.8%

1Y

-24.9%

3Y

-15.9%

5Y

N/A

All

-77.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Efavirenz, emtricitabine and tenofovir disoproxil fumarate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB, manufactured by Laurus Labs Limited, is $1.0725 per EA (NDC 42385091530), effective Nov 18, 2026.

How has the price of EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB changed over time?

Over the history we have for it, the NADAC for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB has declined 77.6%. It has been tracked across 245 weekly CMS publications since Mar 16, 2022.

What are the highest and lowest recorded NADAC prices for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?

Since Mar 16, 2022, the NADAC for EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB has ranged from a low of $1.0725 (Nov 18, 2026) to a high of $5.4841 (Dec 14, 2022), with a median of $1.4793 per EA.

Are there cheaper alternatives to EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB?

EFAVIRENZ-EMTRICITABINE-TENOFOV DISOP FUM 600-200-300 MG TAB (NDC 42385091530) is labeled by Laurus Labs Limited, and CMS classifies it as a generic product.